Archives: Agenda

Best 3 LinkedIn posts from day 1 with hashtag #CTO and @Clinical Trials in Oncology Event Series tagged will win a prize in day 2 morning’s prize draw during chair’s opening remarks. Deadline end of drinks reception day 1. You must be present to win!

Faraz Siddiqui is an experienced healthcare attorney who negotiates clinical research agreements on behalf of Memorial Sloan Kettering with pharmaceutical companies and CROs. His session will cover:

• How Sponsors can collaborate with sites on innovations to accelerate trial activation, in an environment of limited budgets and high study volume.
• Implementation of site-driven legal innovations to streamline contract negotiation frameworks.
• Case Study of MSK’s Early Drug Development (EDD)’s cross-functional pilot (regulatory, legal, operations, finance) to address bottlenecks and improve efficiency in study activation

• Why tissue biopsies are sometimes essential in clinical trials for novel therapeutics
• Question-based framework to align tissue collection and analysis with clinical trial objectives and timelines
• Emerging biomarker technologies including digital pathology, artificial intelligence, and multiplex spatial biology

• The continued development and commercial feasibility of cell and gene therapies require access to the community setting
• With current downward pressures on academic research institutions in the U.S., community sites are ideally primed to help support and drive this clinical development
• Through innovative, strategic positioning of sites, sponsors and vendors, community access to these therapies can accelerate development through increased data collection

• Selecting fit-for-purpose digital endpoints for modern trial design
• Identifying where digital endpoints create meaningful value and understanding why adoption remains limited in many studies
• Case study: current clinical study with multiple digital endpoints. From design to data.
• Practical lessons from real-world trial designs: successes, challenges, and implementation pitfalls

Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will be led by a table moderator and will focus on a different challenge within oncology clinical trials. Roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice

1. Roundtable 1: Making RECIST Work for You: Why you should be using RECIST Plus in your clinical trials
   Hosted by Dr. Rick Patt, Vice President, Medical & Scientific Affairs, RadMD
2. Balancing innovation, speed, and risk in modern clinical development
   Hosted by George Naumov, Chief Operating Officer, RS Oncology
3. Roundtable 3: SITE PERSPECTIVE: Working smarter with legal on clinical trial agreements
   Faraz Siddiqui will draw on his experience advising pharmaceutical companies to demystify clinical trial agreements for non-attorney leaders. This workshop is designed for business and Clinical Operations professionals who want a clearer, practical understanding of how these agreements work—and how to collaborate more effectively with their legal teams throughout the process by discussing common negotiation points; key areas of risks; and strategies to streamline interactions with counsel. This session is intended for educational purposes only and does not constitute legal advice.
   Hosted by Faraz Siddiq, Assistant General Counsel – EDD, Memorial Sloan Kettering Cancer Center
   
4. Roundtable 4: The use of AI in cross-functional data review
   Hosted by Kevin Stephenson, Executive Director, Data Management, Karyopharm Therapeutics

To be in with a chance of winning our LinkedIn prize draw, post your most engaging and/or funniest photo from Day 1 of the conference on LinkedIn by 8:00pm on June 30^th.

Please include the hashtag #CTO and tag both:

• Clinical Trials in Oncology Event Series
• Arena International Events Group

We will shortlist three finalists, and the audience will vote for the winner during the Chairpersons’ Opening Remarks on Day 2.

Please note. You must be present in the room at 8:45am to claim the prize. If the winner is not present, the prize will be awarded to the next finalist in attendance.